Bluebird bio nabs major win with first FDA approval following split


Somerville gene therapy firm bluebird bio Inc. has scored its first approval from the U.S. Food and Drug Administration following its business split late last year.

Previous ARC Health buys Southeast Psych, a group of mental health providers
Next Key Opko Health executive retires